Also, the cell-based manufacturing process of biologics results in undefinable post-translational modifications. Thus, it is impossible to prove whether two biologics are exactly the same in every aspect.
The inherent variability in cell-based manufacturing processes for biologics makes it difficult to guarantee complete uniformity and identicality across all aspects of the product, leading to uncertainty about its exact composition.